(4-((Thiophen-2-ylmethyl)carbamoyl)phenyl)boronic acid, 98%, 250mg

3-Benzyl-7-(phenylsulfonyl)-9-oxa-3,7-diazabicyclo[3.3.1]nonane, 95%, 1g

2,2'':7'',2''''-Ter-9,9'-spirobi[9H-fluorene]>98.0%(HPLC)200mg

(S)-3-((Acetamidomethyl)thio)-2-aminopropanoic acid hydrochloride, 95.0%, 2g

6,6'-Methylenebis(2-cyclohexyl-4-methylphenol), 95.0%, 100g

(S)-2-Amino-3-(3-hydroxyphenyl)propanoic acid, 97.0%, 25g

1,2-Dichloroéthane, min.99%, pour la synthèse, 2,5 L, emballage en verre

4-Ethynylpiperidine hydrochloride, 95.0%, 5g

4-N-Butoxyphenylboronic acid, 95.0%, 1g

4,6-Bis(diphenylphosphino)dibenzofuran, 97%, 5g

4-Chlorothieno[2,3-D]pyrimidine, 98.0%, 25g

(R)-2-Methoxypropan-1-ol, 95.0%, 1g

Tris(2-hydroxyethyl) Isocyanurate>98.0%(N)25g